RaySearch Laboratories (Q3 Review): EBIT beat reinforces take on conservative targets - Redeye
Bildkälla: Stockfoto

RaySearch Laboratories (Q3 Review): EBIT beat reinforces take on conservative targets - Redeye

RaySearch’s Q3 increases our confidence in its potential for profitable sales growth, with accelerating sales drivers as we move into 2026. Though we urge a long-term perspective (given the lumpiness of the business), quarterly reports remain the main trigger to take the share toward our SEK370 base case.

RaySearch’s Q3 increases our confidence in its potential for profitable sales growth, with accelerating sales drivers as we move into 2026. Though we urge a long-term perspective (given the lumpiness of the business), quarterly reports remain the main trigger to take the share toward our SEK370 base case.
Börsvärldens nyhetsbrev